Plain-English answer
The Digital Health and AI Index groups telehealth, internet hospitals, AI, EHRs, interoperability, patient portals, mobile health, wearables, remote monitoring, digital therapeutics, health data, privacy, and cybersecurity pages.
Where technology meets workflow
Digital health, data governance, and workflow: Digital Health and AI Index is a workflow and governance issue before it is a technology issue. FDA materials on AI-enabled medical devices emphasize lifecycle management, transparency, performance monitoring, and the relationship between software changes and marketing submissions. China-facing digital health projects must also account for PIPL, the Data Security Law, the Cybersecurity Law, cross-border data-transfer controls, hospital data ownership, localization of cloud infrastructure, and the operational realities of public hospital IT departments. The adoption question is whether the technology changes a reimbursed, staffed, auditable workflow. Concrete anchor: The Digital Health and AI Index groups telehealth, internet hospitals, AI, EHRs, interoperability, patient portals, mobile health, wearables, remote monitoring, digital therapeutics, health data, privacy, and cybersecurity pages. The primary lens is digital health, AI, data, and cybersecurity pages. Main caution: Treating digital health as an app market rather than a governed workflow.
The page should therefore be read around a concrete operating question: for Digital Health and AI Index, what changes in a real decision? The answer usually depends on data rights, model validation, cybersecurity controls, clinical workflow, reimbursement route, and hospital IT integration. These are the items a company, policymaker, investor, hospital partner, or reader should verify before turning the topic into a strategy. The most useful evidence is not a broad market statistic; it is evidence that shows where the relevant gate sits, how the gate is passed, and what happens after the gate is passed.
For U.S.-China comparison, Digital Health and AI Index also needs translation across institutions. A U.S. reader may look for payer contracts, FDA status, coding, malpractice exposure, and private-provider economics. A China-facing reader may look for NMPA registration, NHSA reimbursement, public-hospital adoption, provincial procurement, local distributor capability, and policy implementation by municipal or provincial authorities. Those are not interchangeable checklists. They point to different documents, different buyers, different timelines, and different failure modes.
| Decision point | What to verify | Why it matters |
|---|---|---|
| Authority | Which regulator, payer, hospital, procurement body, or partner has decision rights for Digital Health and AI Index? | Decision rights determine the first real adoption gate. |
| Evidence | What clinical, economic, technical, compliance, or operational evidence is persuasive in this setting? | Evidence that satisfies one stakeholder may be irrelevant to another. |
| Implementation | Who pays, who uses, who services, who monitors, and who bears risk after adoption? | Execution details decide whether a policy or approval becomes routine practice. |
The common failure mode is treating a software demo as proof of clinical, regulatory, and procurement readiness. A stronger reading is narrower and more practical: define the patient or customer segment, name the decision-maker, state the payment route, identify the evidence threshold, and then decide whether the topic creates a near-term action, a diligence question, or a longer-term market signal.
How this page works
Digital health strategy depends on workflow, payment, data rights, regulatory classification, cybersecurity, interoperability, and adoption accountability.
When to use this page
Use this index when the topic involves software, AI, data, patient-facing tools, EHR integration, or digital-care delivery.
Pages in this cluster
Path table
| Page | Path |
|---|---|
| AI in Healthcare in China | /ai-in-healthcare-in-china.html |
| AI in Healthcare in the United States | /ai-in-healthcare-in-the-united-states.html |
| AI Medical Device Regulation in the U.S. and China | /ai-medical-device-regulation-in-the-us-and-china.html |
| AI Medical Imaging in China | /ai-medical-imaging-in-china.html |
| Air Pollution and Health in China | /air-pollution-and-health-in-china.html |
| Cross-Border Health Data in U.S.-China Healthcare | /cross-border-health-data-in-us-china-healthcare.html |
| Cybersecurity for Medical Devices in China | /cybersecurity-for-medical-devices-in-china.html |
| Cybersecurity Law and Healthcare in China | /cybersecurity-law-and-healthcare-in-china.html |
| Digital Health in the U.S. and China | /digital-health-in-the-us-and-china.html |
| Digital Pathology in China | /digital-pathology-in-china.html |
| Digital Therapeutics in the U.S. and China | /digital-therapeutics-in-the-us-and-china.html |
| Digital Therapeutics Regulation in the U.S. and China | /digital-therapeutics-regulation-in-the-us-and-china.html |
| Electronic Health Records in China | /electronic-health-records-in-china.html |
| Electronic Health Records in the United States | /electronic-health-records-in-the-united-states.html |
| Fuwai Hospital | /fuwai-hospital.html |
| Health Data Infrastructure in China | /health-data-infrastructure-in-china.html |
| Healthcare Anti-Corruption Campaigns in China | /healthcare-anti-corruption-campaigns-in-china.html |
| Healthcare Cybersecurity in the U.S. and China | /healthcare-cybersecurity-in-the-us-and-china.html |
| Healthcare in Shanghai | /healthcare-in-shanghai.html |
| Healthcare Interoperability in the U.S. and China | /healthcare-interoperability-in-the-us-and-china.html |
| HIV/AIDS in China | /hiv-aids-in-china.html |
| Hospital AI Adoption in China | /hospital-ai-adoption-in-china.html |
| Internet Hospitals in China | /internet-hospitals-in-china.html |
| Medicaid Managed Care | /medicaid-managed-care.html |
| Medicaid | /medicaid.html |
| Medical Device Service and Maintenance in China | /medical-device-service-and-maintenance-in-china.html |
| Mobile Health in China | /mobile-health-in-china.html |
| Patient Portals in the U.S. and China | /patient-portals-in-the-us-and-china.html |
| Patriotic Health Campaigns | /patriotic-health-campaigns.html |
| Pharmaceutical Supply Chains and China | /pharmaceutical-supply-chains-and-china.html |
| Remote Patient Monitoring in the U.S. and China | /remote-patient-monitoring-in-the-us-and-china.html |
| Shanghai Sixth People’s Hospital | /shanghai-sixth-peoples-hospital.html |
| Telehealth in China | /telehealth-in-china.html |
| Telehealth in the United States | /telehealth-in-the-united-states.html |
| U.S. Health Data Privacy for Chinese Companies | /us-health-data-privacy-for-chinese-companies.html |
| U.S. vs. China AI Governance in Healthcare | /us-vs-china-ai-governance-in-healthcare.html |
| U.S. vs. China Healthcare Data Privacy | /us-vs-china-healthcare-data-privacy.html |
| U.S. vs. China Telehealth | /us-vs-china-telehealth.html |
| Violence Against Doctors in China | /violence-against-doctors-in-china.html |
| Wearable Health Technology in China | /wearable-health-technology-in-china.html |
| Medicaid 是什么 | /zh/medicaid-是什么.html |
Evidence context
Use this page as an orientation guide; detailed claims should be evaluated on the linked topic pages.
- Digital health pages require regulatory, privacy, cybersecurity, interoperability, implementation, and outcomes evidence.
- Follow the linked topic pages for definitions, evidence context, and analytical frameworks.
- Use the methods pages for evidence grading, citation style, and Chinese-language access policy.